BioVie Inc.
BIVI
$1.46
$0.053.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.17% | 27.71% | 45.39% | 47.66% | 43.90% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -100.00% | -97.01% | -89.05% | -182.07% | -66.10% |
| Total Other Non-Cash Items | -43.10% | -30.11% | -31.91% | 743.18% | 123.02% |
| Change in Net Operating Assets | 122.46% | -236.36% | -4,959.26% | -293.53% | -1,977.08% |
| Cash from Operations | 34.96% | 4.54% | 31.92% | 50.54% | 46.43% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -100.00% |
| Cash from Investing | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 66.50% | 41.50% | -11.33% | -117.00% |
| Issuance of Common Stock | -71.78% | -4.91% | -33.19% | -36.10% | 81.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.09% | 29.02% | -28.52% | -52.59% | 70.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -192.49% | 515.92% | -243.72% | -677.44% | 116.37% |